Vima LLC’s Fulgent Genetics FLGT Stock Holding History

Vima LLC’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,278	Closed	-$39.9K	–	165
2024 Q1	$39.9K	Buy	1,278 +1,158	+965%	+$28.8K	0.05%	128
2023 Q4	$3.47K	Buy	+120	New	+$3.21K	0.01%	318

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vima LLC's FLGT Position: Q2 2024 in Review

Vima LLC sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 1,278 shares — an estimated $39.9K sold.

Vima LLC first reported a position in FLGT in Q4 2023 and held it in 2 quarters. The position peaked at $39.9K in Q1 2024. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

Vima LLC reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
Vima LLC sold 1,278 Fulgent Genetics shares in Q2 2024, an estimated $39.9K.
Vima LLC first reported a position in Fulgent Genetics in Q4 2023 and held it in 2 quarters.
Vima LLC's Fulgent Genetics position peaked at $39.9K in Q1 2024.
173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on Vima LLC's 13F filing for Q2 2024, filed 8 Aug 2024.